LB Pharmaceuticals Inc Common Stock LBRX Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $14.65M+72.6% | $8.48M+251% | $2.42M-0.1% | $2.42M-29.2% | $3.42M+810% | ||
| $7.46M+38.5% | $5.39M+90.6% | $2.83M+16.0% | $2.44M-18.9% | $3.01M-41.7% | ||
| $22.1M+59.4% | $13.87M+164% | $5.25M+8.0% | $4.86M-24.4% | $6.43M+16.1% | ||
| $3.05M+27.1% | $2.4M+42.0% | $1.69M— | $0-100% | $1.12M+139% | ||
| -$19.05M-66.1% | -$11.47M-223% | -$3.56M+27.0% | -$4.87M+8.2% | -$5.31M-4.7% | ||
| $0-100% | $1K— | $0— | $0— | $0-100% | ||
| -$19.05M-66.1% | -$11.47M-223% | -$3.56M+27.0% | -$4.87M+8.2% | -$5.31M-4.6% | ||
| -$0.67— | —— | -$0.61— | —— | -$14.79-5.6% | ||
| -$18.97M-66.6% | -$11.39M-228% | -$3.48M+27.4% | -$4.79M+8.3% | -$5.23M-3.5% | ||
| -$19.05M-66.1% | -$11.47M-223% | -$3.56M+27.0% | -$4.87M+8.2% | -$5.31M-4.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is LB Pharmaceuticals Inc Common Stock profitable?
- LB Pharmaceuticals Inc Common Stock is not currently profitable: it reported a net loss of $39.0M over the trailing twelve months.
- What is LB Pharmaceuticals Inc Common Stock's earnings per share?
- LB Pharmaceuticals Inc Common Stock's diluted EPS over the trailing twelve months is $-30.07.
- Where does LB Pharmaceuticals Inc Common Stock's income statement data come from?
- Every line is extracted from LB Pharmaceuticals Inc Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.